Peter J. Arduini's most recent trade in GE HealthCare Technologies Inc was a trade of 6,303 Common Stock, par value $0.01 per share done at an average price of $70.6 . Disclosure was reported to the exchange on Sept. 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.56 per share. | 03 Sep 2026 | 6,303 | 241,606 | - | 70.6 | 444,740 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.23 per share. | 01 Sep 2026 | 6,043 | 253,381 | - | 71.2 | 430,443 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.23 per share. | 01 Sep 2026 | 5,472 | 247,909 | - | 71.2 | 389,771 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 30 Jun 2026 | 607 | 72,815 | - | - | Deferred Share Units | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 59.92 per share. | 30 Apr 2026 | 4,169 | 259,424 | - | 59.9 | 249,827 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 31 Mar 2026 | 577 | 71,435 | - | - | Deferred Share Units | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | 02 Mar 2026 | 129,140 | 129,140 | - | - | Employee Stock Option (right to buy) | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 49,120 | 255,255 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 74,908 | 239,580 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.20 per share. | 12 Feb 2026 | 33,445 | 206,135 | - | 79.2 | 2,648,844 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 01 Feb 2026 | 3,996 | 70,858 | - | - | Deferred Share Units | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.97 per share. | 01 Feb 2026 | 3,210 | 164,672 | - | 79.0 | 253,494 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 31 Dec 2025 | 625 | 66,116 | - | - | Deferred Share Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 30 Sep 2025 | 748 | 64,620 | - | - | Deferred Share Units | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.73 per share. | 01 Sep 2025 | 5,874 | 173,354 | - | 73.7 | 433,090 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.73 per share. | 01 Sep 2025 | 5,472 | 167,882 | - | 73.7 | 403,451 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 30 Jun 2025 | 729 | 62,988 | - | - | Deferred Share Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 31 Mar 2025 | 553 | 61,491 | - | - | Deferred Share Units | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | 03 Mar 2025 | 119,913 | 119,913 | - | - | Employee Stock Option (right to buy) | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 41,931 | 179,228 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.35 per share. | 01 Mar 2025 | 29,818 | 137,297 | - | 87.3 | 2,604,602 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.35 per share. | 01 Mar 2025 | 4,507 | 167,115 | - | 87.3 | 393,686 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 67,487 | 171,622 | - | 0 | Common Stock, par value $0.01 per share | |
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 01 Feb 2025 | 3,562 | 60,937 | - | - | Deferred Share Units | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.30 per share. | 01 Feb 2025 | 3,206 | 104,135 | - | 88.3 | 283,090 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 31 Dec 2024 | 596 | 56,788 | - | - | Deferred Share Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 30 Sep 2024 | 652 | 55,577 | - | - | Deferred Share Units | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.82 per share. | 01 Sep 2024 | 5,859 | 107,341 | - | 84.8 | 496,960 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 30 Jun 2024 | 825 | 54,249 | - | - | Deferred Share Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 31 Mar 2024 | 645 | 52,708 | - | - | Deferred Share Units | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | 01 Mar 2024 | 103,527 | 103,527 | - | - | Employee Stock Option (right to buy) | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 36,399 | 113,200 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.28 per share. | 01 Mar 2024 | 4,444 | 76,801 | - | 91.3 | 405,648 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 01 Feb 2024 | 4,314 | 52,063 | - | - | Deferred Share Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 31 Dec 2023 | 657 | 47,167 | - | - | Deferred Share Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 30 Sep 2023 | 581 | 45,997 | - | - | Deferred Share Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 30 Jun 2023 | 527 | 44,999 | - | - | Deferred Share Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 31 Mar 2023 | 486 | 44,104 | - | - | Deferred Share Units | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | 01 Mar 2023 | 109,994 | 109,994 | - | - | Employee Stock Option (right to buy) | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 39,425 | 81,245 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | 01 Feb 2023 | 188,127 | 188,127 | - | - | Employee Stock Option (right to buy) | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 21,425 | 41,820 | - | 0 | Common Stock, par value $0.01 per share | |
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 01 Feb 2023 | 2,807 | 43,617 | - | - | Deferred Share Units | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | 04 Jan 2023 | 89,023 | 89,023 | - | - | Employee Stock Option (right to buy) | ||
| GE HealthCare Tech | Mr. Peter J. Arduini | Director, President and CEO | 04 Jan 2023 | 20,395 | 20,395 | - | - | Restricted Stock Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 31 Dec 2022 | 469 | 40,485 | - | - | Deferred Share Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 30 Sep 2022 | 474 | 39,740 | - | - | Deferred Share Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 30 Jun 2022 | 438 | 38,979 | - | - | Deferred Share Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 31 Mar 2022 | 462 | 38,266 | - | - | Deferred Share Units | ||
| General Electric Co. | Mr. Peter J. Arduini | Senior Vice President | 01 Mar 2022 | 63,044 | 63,044 | - | - | Employee Stock Option (right to buy) | ||
| General Electric Co. | Mr. Peter J. Arduini | Senior Vice President | 01 Mar 2022 | 14,443 | 14,443 | - | - | Restricted Stock Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 01 Feb 2022 | 3,067 | 37,803 | - | - | Deferred Share Units | ||
| Bristol-Myers Squibb | Mr. Peter J. Arduini | Director | 31 Dec 2021 | 521 | 34,450 | - | - | Deferred Share Units |